FL H0065 | 2019 | Regular Session

Status

Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Failed on May 3 2019 - 100% progression
Action: 2019-05-03 - Died in Health Quality Subcommittee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishes patient eligibility criteria & requirements relating to access to & use of investigational stem cell treatments; requires DOH to adopt rules; prohibits governmental interference in such treatments; requires institutional review boards to oversee treatments, keep records, & submit reports; prohibits purchase or sale of stem cells; provides penalties.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Stem Cells

Sponsors


History

DateChamberAction
2019-05-03HouseDied in Health Quality Subcommittee
2019-05-03HouseIndefinitely postponed and withdrawn from consideration
2019-03-05HouseIntroduced
2019-01-03HouseReferred to Health Quality Subcommittee; Health Care Appropriations Subcommittee; Health and Human Services Committee
2018-11-29HouseFiled

Same As/Similar To

S954 (Similar To) 2019-05-03 - Died in Health Policy

Code Citations

ChapterArticleSectionCitation TypeStatute Text
385301Amended CodeSee Bill Text
87301Amended CodeSee Bill Text

Florida State Sources


Bill Comments

feedback